Larvol Delta - Aptinyx-Announces-Recommencement-of-Phase-2-Study-of-NYX2925-in-Patients-With-Painful-Diabetic-Peripheral-Neuropathy

NYX-2925 - Aptinyx

https://www.businesswire.com/news/home/20210104005215/en/Aptinyx-Announces-Recommencement-of-Phase-2-Study-of-NYX-2925-in-Patients-With-Painful-Diabetic-Peripheral-Neuropathy

Jan 4, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next